In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Real World Data Solutions For Pharma’s Looming EBIT Crisis

Executive Summary

The global pharmaceutical industry is facing decreasing margins triggered by various internal and external reasons. To address the crisis effectively long term, we see pharma’s integration into care management, combined with data generation and analysis of real-world outcomes, as a way to charge for the value pharma adds.


Related Content

GSK’s Big Push To Maintain Its Respiratory Reign
“Real-World” Breo Study: A Q&A With GSK’s David Leather
Rare Diseases Feature Prominently In Q2 2013 Biopharma Financing
Personalized Medicine Takes Aim At Common Diseases
Priming Russia’s Pharma Industry For Innovation
Roche CEO Severin Schwan: Fueled By Innovation, Emerging Markets
Baxter Acquires Gambro, Becomes Integrated Renal Therapy Leader
The Orphan Drug Boom: Gold Rush Or Flash In The Pan?
Sanofi/Genzyme: Emblematic of What Big Pharma's Buying Now
Pay-for-Performance in the US: What Could Work, What Won't


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts